Hepatology 2007: Vol 46 Index

2007·20.6 MB·English

INDEXES
Author Index to Volume 46*
A Allen TM (see Timm J et al). 2007;46:339- Aviv V (see Meivar-Levy I et al). 2007;46:
349 898-905
A2ALL Study Group (see Trotter JF et al). Aller M (see Thabut D et al). 2007;46: Avsar E (see Tahan V et al). 2007;46:2045
2007;46:1476-1484 1893-1906 (Correspondence)
Abar OT (see Huang H et al). 2007;46: Allgaier R (see Timm J et al). 2007;46:339- Axel B (see NattermannJ et al). 2007;46:
297-306 349 1016-1025
Abdelaziz M (see Kamal SM et al). 2007; Almeida-Porada G (see Chamberlain J et Ayers M (see Feld JJ et al). 2007;46:1057-
46:1732-1740 al). 2007;46:1935-1945 1070
Abe M (see Sumpter TL et al). 2007;46: AlonsoJ (see Rovira A et al). 2007;46: Aymerich FX (see Rovira A et al). 2007;46:
2021-2031 (Review) 1485-1490 1485-1490
Acalovschi M (see Griinhage F et al). 2007; Amancherla K (see Joshi-Barve S et al). Ayonrinde OT and Olynyk JK. Clinical
46:793-801 2007;46:823-830 expression of hemochromatosis gene
Ackermann D, Mordasini D, Cheval L, Ando H (see Matsuzawa N et al). 2007;46: (HFE) variants. 2007;46:960-962
Imbert-Teboul M, Vogt B, Doucet A. 1392-1403 (Editorial)
Sodium retention and ascites Andrei AC (see Fernandes F et al). 2007; Azzariti A (see Bergamini C et al). 2007;46:
formation in a cholestatic mice model: 46:1026-1033 1801-1809
Role of aldosterone and
Antonaci S (see Bergamini C et al). 2007;
mineralocorticoid receptor? 2007;46:
46:1801-1809
173-179
Anzivino C (see Bertolotti M et al). 2007;
Adams D (see Wong LJC et al). 2007;46:
46:1664 (Correspondence)
1218-1227
Appenrodt B (see Giilberg V et al). 2007; BackerJ (see Ewaschuk J et al). 2007;46:
Afdhal N (see Jacobson IM et al). 2007;46:
46:1669 (Correspondence) 841-850
971-981
Arai H (see Morita S et al). 2007;46:188- Backus LI, Boothroyd DB, Phillips BR,
Afdha! NH (see McHutchison JG et al).
199 Mole LA. Predictors of response of
2007;46:1341-1349
Arase Y (see Akuta N et al). 2007;46:1357- U.S. veterans to treatment for the
— (see Pockros PJ et al). 2007;46:324-329
Afendy A (see Calvert VS et al). 2007;46: 1364 hepatitis C virus. 2007;46:37-47
Araujo A (see de Barros Lopes A et al). Bacon B (see Spiegel BMR et al). 2007;46:
166-172, 1315-1316 (Correction)
2007;46:1668 (Correspondence) 113-121
Aguilar-Guisado M (see Pineda JA et al).
Araya V (see Jacobson IM et al). 2007;46: Bacon BR (see McHutchison JG et al).
2007 ;46:622-630
Ahmed IN (see Kamal SM et al). 2007;46: 982-990 2007;46:1341-1349
Archimandritis AJ (see Papatheodoridis GV Bader TF (see FaziliJ et al). 2007;46:607-
1732-1740 et al). 2007;46:606-607 608 (Correspondence)
Aithal GP (see Jackson H et al). 2007;46: (Correspondence) Badou A (see Watanabe A et al). 2007;46:
1131-1137
Akira S (see Sakamori R et al). 2007;46: — (see Tsochatzis E et al). 2007;46:2050- 1509-1518
2051 (Correspondence) Bae EJ, Yang YM, Kim JW, Kim SG.
1564-1573
Akuta N, Suzuki F, Kawamura Y, Yatsuji Argo CK (see Caldwell SH and Argo CK). dIidtehntiiofliectahtiioonne s ofth aat n opvreelv ecnlta ss heopfa tic
H, Sezaki H, Suzuki Y, Hosaka T, 2007 ;46:285-287 (Editorial)
Kobayashi M, Kobayashi M, Arase Y, Arnone M (see Gary-Bobo M et al). 2007; insulin resistance via the adenosine
Ikeda K, Kumada H. Amino acid 46:122-129 monophosphate-activated protein
substitutions in the hepatitis C virus Arora S (see Geppert CMA and Arora S). kinase—p70 ribosomal S6 kinase-1]
pathway. 2007;46:730-739
core region are the important 2007;46:957-959 (Editorial)
Bagnardi V (see Bravi F et al). 2007;46:
predictor of hepatocarcinogenesis. Arrese JE (see Kesteloot F et al). 2007;46:
430-435
2007:46:1357-1364 1620-1631
Bahr MJ (see Volkmann X et al). 2007;46:
Al-Adhami M (see McHutchison JG et al). Arrivé L (see Lewin M et al). 2007;46:658-
1498-1508
2007;46:1341-1349 665 Bai AHC (see Pang EYT et al). 2007;46:
Albert C (see Jacobson IM et al). 2007;46: Arroyo V (see Tugues S et al). 2007;46:
436-445
982-990 1919-1926 Baillie RA (see Puri P et al). 2007;46:1081-
Aleksunes LM (see Maher JM et al). 2007; Asch SM (see Kanwal F et al). 2007;46:
1090
46:1597-1610 1741-1749 Balabaud C (see Bioulac-Sage P et al).
Alisi A, Marcellini M, Nobili V. Asselah T (see Bedossa P et al). 2007;46:
2007 ;46:740-748
Bioinformatics as tool to identify 380-387 — (see Rousseau B et al). 2007;46:1108-
gene/protein-pathways associated with l’Association Nationale des Hépato-
1118
nonalcoholic fatty liver Gastroentérologues des Hépitaux
Baldwin EE (see Wong LJC et al). 2007;46:
disease/nonalcoholic steatohepatitis. Généraux de France (see Nousbaum
1218-1227
2007;46:1306 (Correspondence) JB et al). 2007;46:1669-1670 (Reply)
Balestra D (see Gorman N et al). 2007;46:
Alison MR (see Russo FP et al). 2007;46: Auzinger G (see Bernal W et al). 2007;46:
1927-1934
604-605 (Correspondence) 1844-1852
Balian A (see Hamdi H et al). 2007;46:
1986-1992
Banas A, Teratani T, Yamamoto Y,
Tokuhara M, Takeshita F, Quinn G,
Okochi H, Ochiya T. Adipose tissue-
*July, 1-284; August, 285-610; September, 611-952; October, 953-1316; November 1317-1670; Decem-
ber, 1671-2056. derived mesenchymal stem cells as a
I! AUTHOR INDEX HEPATOLOGY, December 2007
source of human hepatocytes. 2007; Belle SH (see Rosen HR et al). 2007;46: Bienek B (see Nattermann J et al). 2007;46:
46:219-228 350-358 1016-1025
Bandara P (see Cua IHY et al). 2007;46:66- Bellentani S (see Bedogni G et al). 2007;46: Biesta PJ (see Stoop JN et al). 2007;46:699-
73 1387-1391 705
Bantel H (see Volkmann X et al). 2007;46: Bellest L, Eschwége V, Poupon R, Bigger CB (see Lanford RE et al). 2007;46:
1498-1508 Chazouilléres O, Robert A. A 999-1008
Baranova A (see Calvert VS et al). 2007;46: modified international normalized Bigorgne A (see Hamdi H et al). 2007;46:
166-172, 1315-1316 (Correction) ratio as an effective way of 1986-1992
Barois N (see Mousavi SA et al). 2007;46: prothrombin time standardization in Biliary Atresia Research Consortium (see
871-884 hepatology. 2007;46:528-534 DeRusso PA et al). 2007;46:1632-
Barshack I (see Meivar-Levy | et al). 2007; Bellusci S (see Berg T et al). 2007;46:1187- 1638 (Special Article)
46:898-905 1197 Binder M, Kochs G, Bartenschlager R,
Bartenschlager R (see Binder M et al). Bendtsen F (see Krag A et al). 2007;46: Lohmann V. Hepatitis C virus escape
2007;46:1365-1374 1863-1871 from the interferon regulatory factor 3
— (see Steinmann E et al). 2007;46:330- Bensaid M (see Gary-Bobo M et al). 2007; pathway by a passive and active
338 46:122-129 evasion strategy. 2007;46: 1365-1374
— (see Zeisel MB et al). 2007;46:1722- Berg T, Rountree CB, Lee L, Estrada J, Bioulac-Sage P, Rebouissou $, Thomas C,
1731 Sala FG, Choe A, Veltmaat JM, De Blanc JF, Saric J, Sa Cunha A, Rullier
Barth H (see Zeisel MB et al). 2007;46: Langhe S, Lee R, Tsukamoto H A, Cube! G, Couchy G, Imbeaud S,
1722-1731 Crooks GM, Bellusci $, Wang KS. Balabaud C, Zucman-Rossi
Bartholomeusz A (see Lok AS et al). 2007; Fibroblast growth factor 10 is critical J. Hepatocellular adenoma subtype
46:254-265 (Review) for liver growth during embryogenesis classification using molecular markers
Barve SS (see Joshi-Barve S et al). 2007;46: and controls hepatoblast survival via and immunohistochemistry. 2007;46:
823-830 B-catenin activation. 2007;46:1187- 740-748
Bauer A (see Brulport M et al). 2007;46: 1197 — (see Rousseau B et al). 2007;46:1108-
861-870 — (see Derkow K et al). 2007;46:1155- 1118
Baumert TF, Résler C, Malim MH, von 1165 Birgens H (see Ellervik C et al). 2007;46:
Weizsicker F. Hepatitis B virus DNA — (see Mousavi SA et al). 2007;46:871 - 1071-1080
is subject to extensive editing by the 884 Birnkrant D (see Sherman KE et al). 2007;
human deaminase APOBEC3C. — (see NattermannJ et al). 2007;46:1016- 46:2014-2020 (Special Article)
2007;46:682-689 1025 Bissell DM (see Wang B et al). 2007;46:
— (see Zeisel MB et al). 2007;46:1722- — (see Schaefer M et al). 2007;46:991-998 1404-1412
1731 Bergamini C, Sgarra C, Trerotoli P, Lupo Bjérnsson E (see Kalaitzakis E and
Beard MR and Warner FJ. Claudin-1, a L, Azzariti A, Antonaci S, Giannelli Bjérnsson E). 2007;46:949-950
new junction in the hepatitis C virus G. Laminin-5 stimulates (Correspondence)
entry pathway. 2007;46:277-279 hepatocellular carcinoma through a Black AL (see Hines IN et al). 2007;46:
(Hepatology Elsewhere) different function of a6B4 and a3B1 229-241
Beaugrand M (see Ganne-Carrie N et al). integrins. 2007;46:1801-1809 Black M (see Jacobson IM et al). 2007;46:
2007;46:282-283 (Reply) Bernal W, Hall C, Karvellas CJ, Auzinger 982-990
Becker S (see Jacobson IM et al). 2007;46: G, Sizer E, Wendon J. Arterial Blanc JF (see Bioulac-Sage P et al). 2007;
971-981 ammonia and clinical risk factors for 46:740-748
Bedogni G, Miglioli L, Masutti F, encephalopathy and intracranial — (see Rousseau B et al). 2007;46:1108-
Castiglione A, Crocé LS, Tiribelli C, hypertension in acute liver failure. 1118
Bellentani S. Incidence and natural 2007;46:1844-1852 Blei AT (see Hassanein TI et al). 2007;46:
course of fatty liver in the general Bernstein D (see Jacobson IM et al). 2007; 1853-1862
population: The Dionysos Study. 46:971-981 Blomenkamp K (see Lindblad D et al).
2007 ;46:1387-1391 Bertolotti M, Gabbi C, Anzivino C, Carulli 2007;46:1228-1235
Bedossa P, Moucari R, Chelbi E, Asselah L, Carulli N. Changes in bile acid Blum HE (see Zeisel MB et al). 2007;46:
T, Paradis V, Vidaud M, Cazals- synthesis in gallstone disease: Cause, 1722-1731
Hatem D, Boyer N, Valla D, consequence, or neither? 2007;46: Boe GM (see Lazaridis KN et al). 2007;46:
Marcellin P. Evidence for a role of 1664 (Correspondence) 785-792
nonalcoholic steatohepatitis in Best DH and Coleman WB. Bile duct Boélle PY (see Lewin M et al). 2007;46:
hepatitis C: A prospective study. destruction by 4,4’- 658-665
2007 ;46:380-387 diaminodiphenylmethane does not Boffoli D (see Piccoli C et al). 2007;46:58-
— (see Paradis V et al). 2007;46:140-146 block the small hepatocyte-like 65
Beer M (see Peyer AK et al). 2007;46:1960- progenitor cell response in retrorsine- Bogdanos DP (see Longhi MS et al). 2007;
1970 exposed rats. 2007;46:1611-1619 46:47 2-484
Beerheide W (see Brulport M et al). 2007; Bezerra JA (see DeRusso PA et al). 2007; BoixJ (see Cauli O et al). 2007;46:514-519
46:861-870 46:1632-1638 (Special Article) Boles RG (see Wong LJC et al). 2007;46:
Beer-Stolz D (see Jin X et al). 2007;46:802- — (see Sokol RJ et al). 2007;46:566-58 1 1218-1227
812 (Review) Bolus R (see Spiegel BMR et al). 2007;46:
Belanger M (see Rose C et al). 2007;46: Bhattacharya R (see Nelson JE et al). 2007; 113-121
1883-1892 46:723-729 Bonacini M (see Peters MG et al). 2007;46:
Belder R (see Lewis JH et al). 2007;46: Bhattacharya T (see Timm J et al). 2007; 769-775
1453-1463 46:339-349 Bonnefont-Rousselot D (see Thabut D et
BelghitiJ (see Paradis V et al). 2007;46: Biecker E (see TrebickaJ et al). 2007;46: al). 2007;46:1893-1906
140-146 242-253 Bonorino P, Leroy V, Dufeu-Duchesne T,
HEPATOLOGY, Vol. 46, No. 6, 2007 AUTHOR INDEX __ Ill
Tongiani-Dashan S, Sturm N, Brooks HF (see Wright G et al). 2007;46: hepatocyte mitochondria in human
Pernollet M, Vivier E, Zarski JP, 610 (Correction) nonalcoholic steatohepatitis. 2007;46:
Marche PN, Jouvin-Marche E. Brown RS Jr (see Hassanein T] et al). 2007; 1101-1107
Features and distribution of CD8 T 46:1853-1862 — and Argo CK. Divergent effects of
cells with human leukocyte antigen — (see Jacobson IM et al). 2007;46:971- peroxisome proliferator—activated
class I—specific receptor expression in 981, 982-990 receptor-y ligands in human and
chronic hepatitis C. 2007;46:1375- Brulport M, Schormann W, Bauer A, mouse nonalcoholic steatohepatitis.
1386 Hermes M, Elsner C, Hammersen FJ, 2007;46:285-287 (Editorial)
Boothroyd DB (see Backus LI et al). 2007; Beerheide W, Spitkovsky D, Hiartig Callewaert N (see Liu XE et al). 2007;46:
46:37-47 W, Nussler A, Horn LC, Edelmann J, 1426-1435
Borg B (see Lutchman G et al). 2007;46: Pelz-Ackermann O, Petersen J, Calvert VS, Collantes R, Elariny H, Afendy
Kamprad M, von Mach M, Lupp A,
424-429 A, Baranova A, Mendoza M,
— (see Yee LJ et al). 2007;46:74-83 Zulewski H, Hengstler JG. Fate of Goodman Z, Liotta LA, Petricoin EF,
extrahepatic human stem and
Bosca L (see Mayoral R et al). 2007;46: Younossi ZM. A systems biology
precursor cells after transplantation
813-822 approach to the pathogenesis of
Bosch J (see Fernandez M et al). 2007;46: into mouse livers. 2007;46:86 1-870 obesity-related nonalcoholic fatty liver
1208-1217 Brunetti-Pierri N (see Wong LJC et al). disease using reverse phase protein
Bosetti C (see Bravi F et al). 2007;46:430- 2007;46:1218-1227 microarrays for multiplexed cell
Bruno R (see Nattermann J et al). 2007;46:
435, 2047 (Correspondence) signaling analysis. 2007;46:166-172,
1016-1025
Bossi I (see Selmi C et al). 2007;46:1836- 1315-1316 (Correction)
Bruno S, Crosignani A, Maisonneuve P,
1843 Cam M (see Feld JJ et al). 2007;46:1548-
Rossi S, Silini E, Mondelli MU.
Bouchete-Delbos L (see Hamdi H et al). 1563
Hepatitis C virus genotype 1b as a
2007;46:1986-1992 major risk factor associated with Cam MC (see Cui Y et al). 2007;46:504-
Bourliere M (see Halfon P et al). 2007;46: hepatocellular carcinoma in patients 513
280-281 (Correspondence) with cirrhosis: A seventeen-year Camacho A (see Pineda JA et al). 2007;46:
Bouvier-Alias M (see Chevaliez S et al). prospective cohort study. 2007;46: 622-630
2007;46:22-31 Cameron PU (see Chang JJ et al). 2007;46:
1350-1356
Bove KE (see Wong LJC et al). 2007;46: Brunt EM (see Caldwell SH et al). 2007; 1332-1340
1218-1227 46:1101-1107 Camp DG II (see Diamond DL et al).
Bowlus CL (see Selmi C et al). 2007;46: Biichler MW (see Herr I et al). 2007;46: 2007;46:649-657
1836-1843 266-274 (Review) Canron X (see Rousseau B et al). 2007;46:
Boyault S (see Rousseau B et al). 2007;46: Buricchi F (see Fiaschi T et al). 2007;46: 1108-1118
1108-1118 130-139 Capasso M (see Persico M et al). 2007;46:
Boyer N (see Bedossa P et al). 2007;46: Burton JR Jr (see Rosen HR et al). 2007; 1009-1015
380-387 46:350-358 Capitanio N (see Piccoli C et al). 2007;46:
Boyer TD (see Peters MG et al). 2007;46: Busch MP (see Tseng FC et al). 2007;46: 58-65
769-775 666-67| Carbonell N (see Thabut D et al). 2007;46:
Brander C (see Timm J et al). 2007;46: Buster EHC], Hansen BE, Buti M, 1872-1882
339-349 Delwaide J, Niederau C, Michielsen Card TR (see Jackson H et al). 2007;46:
Brasky KM (see Lanford RE et al). 2007; PP, Flisiak R, Zondervan PE, Schalm 1131-1137
46:999-1008 SW, Janssen HLA. Peginterferon Carey W (see Garcia-Tsao G et al). 2007;
Brass CA (see Jacobson IM et al). 2007;46: alpha-2b is safe and effective in 46:922-938 (AASLD Practice
971-981, 982-990 HBeAg-positive chronic hepatitis B Guidelines), 2052 (Correction)
BrauckhoffA (see Singer S et al). 2007;46: patients with advanced fibrosis. 2007; Carithers RL Jr (see Diamond DL et al).
759-768 46:388-394 2007 ;46:649-657
Bravi F, Bosetti C, La Vecchia C. Coffee Buti M (see Buster EHC] et al). 2007;46: Carmeliet P (see Tugues S et al). 2007;46:
and hepatocellular carcinoma: Cause 388-394 1919-1926
or confounding? 2007;46:2047 Butler T (see Van der Poorten D et al). Carpenter HA (see Montano-Loza AJ et al).
(Correspondence) 2007;46:1750-1758 2007;46:1138-1145
Byrd CL (see Hines IN et al). 2007;46:229-
—, Bosetti C, Tavani A, Bagnardi V, Carr BI (see Wang Z et al). 2007;46:2003-
Gallus S, Negri E, Franceschi S, La 241 2013
Byun KS (see Yoo BC et al). 2007;46:1041-
Vecchia C. Coffee drinking and Carter-Kent C, Radhakrishnan K,
hepatocellular carcinoma risk: A meta- 1048 Feldstein AE. Increasing calories,
analysis. 2007;46:430-435 Bzowej N (see Huang H et al). 2007;46: decreasing morbidity and mortality: Is
Bréchot C (see Sobesky R et al). 2007;46: 297-306 improved nutrition the answer to
1704-1712 better outcomes in patients with
Breitkopf K (see Weng HL et al). 2007;46: biliary atresia? 2007;46:1329-1331
c
1257-1270 (Editorial)
Brenner DA (see Mencin A et al). 2007;46: Cadranel JF (see Nousbaum JB et al). 2007; Carulli L (see Bertolotti M et al). 2007;46:
1443-1452 46:1669-1670 (Reply) 1664 (Correspondence)
Breuhahn K (see Singer S et al). 2007;46: Caldwell C (see Yood MU et al). 2007;46: Carulli N (see Bertolotti M et al). 2007;46:
759-768 107-112 1664 (Correspondence)
Brillet R (see Chevaliez S et al). 2007;46: Caldwell SH, Patrie JT, Brunt EM, Redick Caruso D (see Mitro N et al). 2007;46:885-
22-31 JA, Davis CA, Park SH, 897
Broering R (see Wu J et al). 2007;46:1769- Neuschwander-Tetri BA. The effects Carvalho Filho RJ (see Schiavon LL et al).
1778 of 48 weeks of rosiglitazone on 2007;46:307-314
IV. AUTHOR INDEX HEPATOLOGY, December 2007
Cassard-Doulcier AM (see Hamdi H et al). specific T cells differ in the liver and — and Sanyal AJ. “Buffalo” hump in
2007;46:1986-1992 blood in chronic hepatitis B virus nonalcoholic fatty liver disease. 2007;
Castellote J. Spontaneous bacterial infection. 2007;46:1332-1340 46:1312 (Reply)
peritonitis and reagent strips. 2007; Chang S (see Szabo G et al). 2007;46:1279- — (see Puri P et al). 2007;46:1081-1090
46:1667-1668 (Correspondence) 1290 (Review) Cheung RC (see Huang H et al). 2007;46:
Castera L (see Ganne-Carrie N et al). 2007; Chantarangkul V (see Tripodi A et al). 297-306
46:282-283 (Reply) 2007:46:520-527 Cheung SKF (see Hui CK et al). 2007;46:
Castiglione A (see Bedogni G et al). 2007; Chao Y (see Su JM et al). 2007;46:402-413 395-401
46:1387-1391 Chavez D (see Lanford RE et al). 2007;46: Cheval L (see Ackermann D et al). 2007;
Catanese JJ (see Huang H et al). 2007;46: 999-1008 46:173-179
297-306 Chawla YK (see Dhiman RK et al). 2007; Chevaliez S, Bouvier-Alias M, Brillet R,
Cauli O, Rodrigo R, Piedrafita B, Boix J, 46:951 (Reply) Pawlotsky JM. Overestimation and
Felipo V. Inflammation and hepatic Chazouilléres O (see Bellest L et al). 2007; underestimation of hepatitis C virus
encephalopathy: Ibuprofen restores 46:528-534 RNA levels in a widely used real-time
learning ability in rats with portacaval Chelbi E (see Bedossa P et al). 2007;46: polymerase chain reaction— based
shunts. 2007;46:514-519 380-387 method. 2007;46:22-31
Cave M (see Joshi-Barve S et al). 2007;46: Chen C (see Liu XE et al). 2007;46:1426- Chiang EP (see Liu SP et al). 2007;46:
823-830 1435 1413-1425
Cazals-Hatem D (see Bedossa P et al). Chen CS (see Lu YS et al). 2007;46:1119- Chiang JYL (see Song KH et al). 2007;46:
2007 ;46:380-387 1130 1993-2002
Cederbaum Al (see Dey A and Cederbaum Chen ML (see Chou YC et al). 2007;46: Chiarugi P (see Fiaschi T et al). 2007;46:
Al). 2007;46:610 (Correction) 672-681 130-139
Celikel C (see Tahan V et al). 2007;46: Chen SY (see Wen WH et al). 2007;46:84- Cho M (see Yoo BC et al). 2007;46:1041-
2045 (Correspondence) 94
1048
Chabbert M (see Gary-Bobo M et al). Chen TJ (see Lu YS et al). 2007;46:1119-
Cho SH (see Yoo BC et al). 2007;46:1041-
2007;46:122-129 1130
1048
Chacon ABV (see Mitro N et al). 2007;46: Chen W (see Cui Y et al). 2007;46:504-
Choe A (see Berg T et al). 2007;46:1187-
885-897 513
1197
Chalasani N (see Nelson JE et al). 2007;46: — (see Feld JJ et al). 2007;46:1548-1563
Choi JY (see Yoo BC et al). 2007;46:1041-
723-729 Chen Y, Lin MC, Yao H, Wang H, Zhang
1048
Chamberlain J, Yamagami T, Colletti E, AQ, Yu J, Hui C, Lau GK, He M,
Choi SK (see Yoo BC et al). 2007;46:1041-
Theise ND, Desai J, Frias A, Pixley J, Sung J, Kung H. Lentivirus-mediated
Zanjani ED, Porada CD, Almeida- RNA interference targeting enhancer 1048
Chon CY (see Yoo BC et al). 2007;46:
Porada G. Efficient generation of of zeste homolog 2 inhibits
human hepatocytes by the hepatocellular carcinoma growth 1041-1048
Chong CL (see Chou YC et al). 2007;46:
intrahepatic delivery of clonal human through down-regulation of stathmin.
672-681
mesenchymal stem cells in fetal sheep. 2007;46:200-208, 1314 (Correction)
Chou PC (see Wong LJC et al). 2007;46:
2007 ;46:1935-1945 —, Wei H, Sun R, Dong Z, Zhang J, Tian
Champaulkt A (see Paradis V et al). 2007; Z. Increased susceptibility to liver 1218-1227
Chou YC, Chen ML, Hu CP, Chen YL,
46:140-146 injury in hepatitis B virus transgenic
Chong CL, Tsai YL, Lin TL, Jeng KS,
Chan C (seeJ i C et al). 2007;46:1586- mice involves NKG2D-ligand
Chang C. Transforming growth
1596 interaction and natural killer cells.
factor-B1 suppresses hepatitis B virus
Chan EP (see Li Z et al). 2007;46:1246- 2007;46:706-715, 1314 (Correction)
replication primarily through
1256 — (see Maher JM et al). 2007;46:1597-
transcriptional inhibition of
Chan HLY, Ren H, Chow WC, Wee T. 1610
Randomized trial of interferon beta- Chen YJ (see Liu SP et al). 2007;46:1413- pregenomic RNA. 2007;46:672-68 1
Choudhury J (see Puri P et al). 2007;46:
la with or without ribavirin in Asian 1425
patients with chronic hepatitis C. Chen YL (see Chou YC et al). 2007;46: 1081-1090
Chow WC (see Chan HLY et al). 2007;46:
2007 ;46:315-323 672-681
Chan JY (see Maher JM et al). 2007;46: Chen YMA (see Liu SP et al). 2007;46: 315-323
Christen V, Treves S, Duong FHT, Heim
1597-1610 1413-1425
Chan L (see HuangJ et al). 2007;46:147- Chen YQ (see Ocrtel M et al). 2007;46: MH. Activation of endoplasmic
157 1236-1245 reticulum stress response by hepatitis
Chand N (see Sanyal A and Chand N). Chen Z (see Laskus T et al). 2007;46:359- viruses up-regulates protein
2007;46:604 (Reply) 370 phosphatase 2A. 2007;46:558-565
Chandalia M (see Vega GL et al). 2007;46: Cheng AL (see Lu YS et al). 2007;46:1119- Chu HM (see Forestier N et al). 2007;46:
716-722 1130 640-648
Chang C (see Chou YC et al). 2007;46: Chesler EJ (see Gatti D et al). 2007;46: Chung RT (see Timm J et al). 2007;46:
672-681 548-557 339-349
Chang ET (see Lin SY et al). 2007;46: Cheung O, Kapoor A, Puri P, Sistrun S, Chung YH (see Yoo BC et al). 2007;46:
1034-1040 Luketic VA, Sargeant CC, Contos 1041-1048
Chang FY (see Su JM et al). 2007;46:402- MJ, Shiffman ML, Stravitz RT, Churchill T (see EwaschukJ et al). 2007;
413 Sterling RK, Sanyal AJ. The impact of 46:84 1-850
Chang JJ, Thompson AJV, Visvanathan K, fat distribution on the severity of Ciocan A (see Griinhage F et al). 2007;46:
Kent SJ, Cameron PU, Wightman F, nonalcoholic fatty liver disease and 793-801
Desmond P, Locarnini SA, Lewin SR. metabolic syndrome. 2007;46:1091- Ciuclan L (see Weng HL et al). 2007;46:
The phenotype of hepatitis B virus— 1100 1257-1270
HEPATOLOGY, Vol. 46, No. 6, 2007 AUTHOR INDEX V
Clotet B (see NattermannJ et al). 2007;46: — and George J. Adipokines and insulin de Barros Lopes A, Araujo A, Reis Alvares-
1016-1025 resistance in chronic hepatitis C. da Silva M. Lower cutoff values for
Club Francophone pour I’Etude de 2007;46:2051 (Reply) dipsticks may improve their accuracy
Hypertension Portale (see Nousbaum Cubel G (see Bioulac-Sage P et al). 2007; in rapid diagnosis of spontaneous
JB et al). 2007;46:1669-1670 (Reply) 46:740-748 bacterial peritonitis. 2007;46:1668
Cohen GM (see Volkmann X et al). 2007; Cui Y, Hosui A, Sun R, Shen K, Gavrilova (Correspondence)
46:1498-1508 O, Chen W, Cam MC, Gao B, De Bruyne R (see Mitry RR et al). 2007;46:
Cole M (see Rousseau B et al). 2007;46: Robinson GW, Hennighausen L. Loss 2047-2048 (Correspondence)
1108-1118 of signal transducer and activator of De Fabiani E (see Mitro N et al). 2007;46:
Coleman WB (see Best DH and Coleman transcription 5 leads to hepatosteatosis 885-897
WB). 2007;46:1611-1619 and impaired liver regeneration. 2007; de la Monte S (see He J et al). 2007;46:
Colige A (see Kesteloot F et al). 2007;46: 46:504-513 1791-1800
1620-1631 Czaja AJ (see Montano-Loza AJ et al). De Langhe S (see Berg T et al). 2007;46:
Collantes R (see Calvert VS et al). 2007;46: 2007;46:1138-1145 1187-1197
166-172, 1315-1316 (Correction) de Ledinghen V (see Ganne-Carrie N et al).
Colletti E (see Chamberlain J et al). 2007; 2007;46:282-283 (Reply)
46:1935-1945 De Minicis S (see Mencin A et al). 2007;
Collier J. Bone disorders in chronic liver 46:1443-1452
Dahari H, Ribeiro RM, Perelson AS.
disease. 2007;46:1271-1278 (Review) deGiacomo M (see Laskus T et al). 2007;
Triphasic decline of hepatitis C virus
Combes B (see Peters MG et al). 2007;46: 46:359-370
RNA during antiviral therapy. 2007;
769-775 Del RA, Post AB, Singer ME. Is there a
46:16-21
Contos MJ (see Cheung O et al). 2007;46: — and Perelson AS. Hepatitis C virus difference in the cost-effectiveness of
1091-1100 erythropoietic therapies for the
kinetics in chimeric mice during
— (see Puri P et al). 2007;46:1081-1090 antiviral therapy. 2007;46:2048-2049 treatment of anemia in patients
Contreras R (see Liu XE et al). 2007;46: (Correspondence) receiving HCV combination therapy?
1426-1435 2007;46:283-284 (Reply)
Dahl R (see Soden JS et al). 2007;46:485-
CérdobaJ (see Rovira A et al). 2007;46: del ValleJ (see Pineda JA et al). 2007;46:
495
1485-1490 Dahms BB (see Wong LJC et al). 2007;46: 622-630
Corpechot C and Poupon R. Delaveaucoupet J (see Hamdi H et al).
1218-1227
Geotherapeutics of primary biliary 2007;46:1986-1992
Dalton TP (see Maher JM et al). 2007;46:
cirrhosis: Bright and sunny around Dell’Era A (see Tripodi A et al). 2007;46:
1597-1610
the Mediterranean but still cloudy and 520-527
Daniels MG (see Timm J et al). 2007;46:
foggy in the United Kingdom. 2007; DelwaideJ (see Buster EHCJ et al). 2007;
339-349
46:963-965 (Editorial), 2052 46:388-394
Danta M (see NattermannJ et al). 2007;
(Correction) 46:1016-1025 Demetris AJ (see Lunz JG III et al). 2007;
Cosset LF (see Zeisel MB et al). 2007;46: D’Aprile A (see Piccoli C et al). 2007;46: 46:1946-1959
1722-1731 58-65 Denk H (see Stumptner C et al). 2007;46:
Costet P (see Rousseau B et al). 2007;46: Davenport M, Stringer MD, Tizzard SA, 851-860
1108-1118 McClean P, Mieli-Vergani G, Hadzic Derian N (see Sobesky R et al). 2007;46:
Couchy G (see Bioulac-Sage P et al). 2007; N. Randomized, double-blind, 1704-1712
46:740-748 placebo-controlled trial of Derkow K, Loddenkemper C, Mintern J,
Cozzi G (see Fiaschi T et al). 2007;46:130- corticosteroids after Kasai Kruse N, Klugewitz K, Berg T,
139 portoenterostomy for biliary atresia. Wiedenmann B, Ploegh HL, Schott
Craigen WJ (see Wong LJC et al). 2007;46: E. Differential priming of CD8 and
2007;46:1821-1827
1218-1227 — (see Narayanaswamy B et al). 2007;46: CD4 T-cells in animal models of
Crestani M (see Mitro N et al). 2007;46: 180-187 autoimmune hepatitis and cholangitis.
885-897 Davern T]. Predicting prognosis in acute 2007;46:1155-1165
Crist C (see Harrison-Findik DD et al). liver failure: Ammonia and the risk of DeRusso PA, Ye W, Shepherd R, Haber
2007;46:1979-1985 cerebral edema. 2007;46:1679-1681 BA, Shneider BL, Whitington PF,
Crocé L (see Persico M et al). 2007;46: (Editorial) Schwarz KB, Bezerra JA, Rosenthal P,
1009-1015 Davies C (see Wright G et al). 2007;46:610 Karpen S, Squires RH, Magee JC,
Crocé LS (see Bedogni G et al). 2007;46: (Correction) Robuck PR, Sokol RJ, Biliary Atresia
1387-1391 Davies NA (see Mookerjee RP et al). 2007; Research Consortium. Growth failure
Croci T (see Gary-Bobo M et al). 2007;46: 46:83 1-840, 2052 (Correction) and outcomes in infants with biliary
122-129 — (see Rose C et al). 2007;46:1883-1892 atresia: A report from the Biliary
Crooks GM (see Berg T et al). 2007;46: — (see Wright G et al). 2007;46:610 Atresia Research Consortium. 2007;
1187-1197 (Correction) 46:1632-1638 (Special Article)
Crosignani A (see Bruno S et al). 2007;46: Davis C (see Morford LA). 2007;46:1541- Desai J (see Chamberlain J et al). 2007;46:
1350-1356 1547 1935-1945
Cruccioli N (see Gary-Bobo M et al). 2007; Davis CA (see Caldwell SH et al). 2007;46: Deschamps L (see Paradis V et al). 2007;46:
46:122-129 1101-1107 140-146
Cua IHY, Hui JM, Bandara P, Kench JG, Davis HL (see McHutchison JG et al). Desmond P (see Chang JJ et al). 2007;46:
Farrell GC, McCaughan GW, George 2007;46:1341-1349 1332-1340
J. Insulin resistance and liver injury in Davis PA (see Leung PSC). 2007;46:1436- Desmouliére A (see Kesteloot F et al). 2007;
hepatitis C is not associated with 1442 46:1620-1631
virus-specific changes in de Andrade M (see Lazaridis KN et al). Desmyter L (see Liu XE et al). 2007;46:
adipocytokines. 2007;46:66-73 2007;46:785-792 1426-1435
VI AUTHOR INDEX HEPATOLOGY, December 2007
Devereaux MW (see Soden JS et al). 2007; Dragutsky MS (see Jacobson IM et al). Erlich H (see Rosen HR et al). 2007;46:
46:485-495 2007 ;46:982-990 350-358
Dewaele S (see Liu XE et al). 2007;46: DranofJfA (see Li Z et al). 2007;46:1246- Eschwége V (see Bellest L et al). 2007;46:
1426-1435 1256 528-534
Dey A and Cederbaum AI. Induction of Dufeu-Duchesne T (see Bonorino P et al). Esrailian E (see Spiegel BMR et al). 2007;
cytochrome P450 2E1 promotes liver 2007;46:1375-1386 46:113-121
injury in ob/ob mice. 2007;46:610 Duh MS (see Wu WK et al). 2007;46:283 EstradaJ (see Berg T et al). 2007;46:1187-
(Correction) (Correspondence) 1197
Dhalluin-Venier V (see Vallet-Pichard A et Duhamel C (see Thabut D et al). 2007;46: Evans J (see Harrison-Findik DD et al).
al). 2007;46:32-36 1872-1882 2007;46:1979-1985
Dhawan A (see Mitry RR et al). 2007;46: Duncan J (see Timm J et al). 2007;46:339- Everhart JE (see Trotter JF et al). 2007;46:
2047-2048 (Correspondence) 349 1476-1484
Duong FHT (see Christen V et al). 2007; Ewaschuk J, Endersby R, Thiel D, Diaz H,
Dhiman RK, Duseja A, Chawla YK.
Should impaired liver function be 46:558-565 Backer J, Ma M, Churchill T, Madsen
Durand-Gasselin I (see Hamdi H et al). K. Probiotic bacteria prevent hepatic
held responsible for cognitive
impairment and poor health-related 2007;46:1986-1992 damage and maintain colonic barrier
Durazo F (see Spiegel BMR et al). 2007;46: function in a mouse model of sepsis.
quality of life in alcoholic cirrhosis?.
113-121 2007;46:84 1-850
2007;46:951 (Reply)
Duseja A (see Dhiman RK et al). 2007;46: Ezaki O (see Yamazaki T et al). 2007;46:
Dhumeaux D (see Ganne-Carrie N et al).
951 (Reply) 1779-1790
2007;46:282-283 (Reply) Dwek RA (see Steinmann E et al). 2007;46:
Di Bisceglie AM (see Peters MG et al).
330-338
2007;46:769-775 F
Di Martino V (see Thévenot T et al). 2007;
46:1308-1309 (Reply) Fabris F (see Tripodi A et al). 2007;46:520-
Diamond DL, Jacobs JM, Paeper B, Proll 527
SC, Gritsenko MA, Carithers RL Jr, Eagle TM (see Ganey PE et al). 2007;46: Fair JH (see Trotter JF et al). 2007;46:
Larson AM, Yeh MM, Camp DG II, 1177-1186 1476-1484
Smith RD, Katze MG. Proteomic Ebrahim S (see Fraser A et al). 2007;46: Fan ST (see Hui CK et al). 2007;46:690-
profiling of human liver biopsies: 158-165 698
Hepatitis C virus-induced fibrosis and EdelmannJ (see Brulport M et al). 2007; Fang Y (see Xu R). 2007;46:1810-1820
mitochondrial dysfunction. 2007;46: 46:861-870 Farges O (see Thabut D et al). 2007;46:
649-657 Edlin BR (see Tseng FC et al). 2007;46: 1893-1906
Diaz H (see EwaschukJ et al). 2007;46: 666-67 1 Farrell GC (see Cua IHY et al). 2007;46:
841-850 Efler SM (see McHutchison JG et al). 66-73
Diaz-Sanjuan T (see Garcia-Ruiz I et al). 2007;46:1341-1349 Fazili J, Bader TF, Tierney W. Treating
2007;46:4 14-423 Ehemann V (see Singer S et al). 2007;46: acute hepatitis B. 2007;46:607-608
Dickson ER (see Lazaridis KN et al). 2007; 759-768 (Correspondence)
Ehleben C (see Pearlman BL et al). 2007; Feld JJ, Ayers M, El-Ashry D, Mazzulli T,
46:785-792
Dieter MZ (see Maher JM et al). 2007;46: 46:1688-1694 Tellier R, Heathcote EJ. Hepatitis B
Eisen S (see Kanwal F et al). 2007;46:1741- virus DNA prediction rules for
1597-1610
Dittmer U (see Wu J et al). 2007;46:1769- 1749 hepatitis B e antigen—negative chronic
El Kamary SS (see Kamal SM et al). 2007; hepatitis B. 2007;46:1057-1070
1778
Dobierzewska A (see Morford LA). 2007; 46:1732-1740 —, Nanda S, Huang Y, Chen W, Cam M,
Elachouri G (see Gary-Bobo M et al). Pusek SN, Schweigler LM, Theodore
46:1541-1547
— (see Rutkute K et al). 2007;46:1 166- 2007;46:122-129 D, Zacks SL, Liang TJ, Fried MW.
Elariny H (see Calvert VS et al). 2007;46: Hepatic gene expression during
1176 166-172, 1315-1316 (Correction) treatment with peginterferon and
Doffoel M (see Zeisel MB et al). 2007;46:
El-Ashry D (see Feld JJ et al). 2007;46: ribavirin: Identifying molecular
1722-1731
Dolganiuc A (see Szabo G et al). 2007;46: 1057-1070 pathways for treatment response.
Ellervik C, Birgens H, Tybjarg-Hansen A, 2007;46:1548-1563
1279-1290 (Review)
Nordestgaard BG. Hemochromatosis Feldstein AE (see Carter-Kent C et al).
Dolinski BM (see Wang B et al). 2007;46: genotypes and risk of 31 disease 2007 ;46:1329-1331 (Editorial)
1404-1412 endpoints: Meta-analyses including — (see Wieckowska A et al). 2007;46:582-
Dominitz JA (see Kanwal F et al). 2007;46:
66,000 cases and 226,000 controls. 589 (Review), 2048 (Reply)
1741-1749 2007;46:1071-1080 Felipo V (see Cauli O et al). 2007;46:514-
Dong MH (see Saab S et al). 2007;46:
Ellis E (see Song KH et al). 2007;46:1993- 519
1049-1056 2002 Feray C (see Sobesky R et al). 2007;46:
Dong Z (see Chen Y et al). 2007;46:706- Elsharkawy AM and Mann DA. Nuclear 1704-1712
715, 1314 (Correction) factor-KB and the hepatic Ferber S (see Meivar-Levy I et al). 2007;46:
Dooley S (see Weng HL et al). 2007;46: inflammation-fibrosis-cancer axis. 898-905
1257-1270 2007;46:590-597 (Review) Ferenci P and Kramer L. MARS and the
Dos Santos A (see Sobesky R et al). 2007; Elsner C (see Brulport M et al). 2007;46: failing liver—Any help from the outer
46:1704-1712 861-870 space? 2007;46: 1682-1684 (Editorial)
Doucet A (see Ackermann D et al). 2007; Emilie D (see Hamdi H et al). 2007;46: Fernandes F, Poole DS, Hoover S,
46:173-179 1986-1992 Middleton R, Andrei AC, Gerstner J,
Douvin C (see Ganne-Carrie N et al). Endersby R (see EwaschukJ et al). 2007; Striker R. Sensitivity of hepatitis C
2007 ;46:282-283 (Reply) 46:84 1-850 virus to cyclosporin A depends on
HEPATOLOGY, Vol. 46, No. 6, 2007 AUTHOR INDEX _ VII
nonstructural proteins NSSA and Fraquelli M and Rigamonti C. Diagnosis Ganne-Carrie N, de Ledinghen V,
NSS5B. 2007;46:1026-1033 of cirrhosis by transient elastography: Marcellin P, Dhumeaux D,
Fernandez M, Mejias M, Garcia-Pras E, What is hidden behind misleading Beaugrand M, Ziol M, Douvin C,
Mendez R, Garcia-Pagan JC, Bosch J. results. 2007;46:282 Castera L, Trinchet JC. Diagnosis of
Reversal of portal hypertension and (Correspondence) cirrhosis by transient elastography:
hyperdynamic splanchnic circulation Fraser A, Ebrahim S, Smith GD, Lawlor What is hidden behind misleading
by combined vascular endothelial DA. A comparison of associations of results. 2007;46:282-283 (Reply)
growth factor and platelet-derived alanine aminotransferase and gamma- Gao B (see Cui Y et al). 2007;46:504-513
growth factor blockade in rats. 2007; glutamyltransferase with fasting Gao CF (see Liu XE et al). 2007;46:1426-
46:1208-1217 glucose, fasting insulin, and glycated 1435
Fernandez-Martinez A (see Mayoral R et hemoglobin in women with and Gao H (see Wen WH et al). 2007;46:84-94
al). 2007;46:81 3-822 without diabetes. 2007;46:158-165 Garcia-Garcia JA (see Pineda JA et al).
Fernandez-Varo G (see Tugues S et al). Freeman RB Jr. Is waiting time a measure 2007;46:622-630
2007;46:1919-1926 of access to liver transplantation? Is Garcia-Pagan JC (see Fernandez M et al).
Ferraz MLG (see Schiavon LL et al). 2007; shorter necessarily better? 2007;46: 2007;46:1208-1217
602-603 (Hepatology Elsewhere)
46:307-314 Garcia-Pras E (see Fernandez M et al).
Fiaschi T, Buricchi F, Cozzi G, Matthias S, Freilich B (see Jacobson IM et al). 2007;46:
2007;46:1208-1217
Parri M, Raugei G, Ramponi G, 971-981, 982-990 Garcia-Ruiz I, Rodriguez-Juan C, Diaz-
Chiarugi P. Redox-dependent and Frias A (see Chamberlain J et al). 2007;46:
Sanjuan T, Martinez MA, Mufioz-
ligand-independent ¢rans-activation of 1935-1945 Yagiie T, Solis-Herruzo JA. Effects of
insulin receptor by globular Friebe A (see Schaefer M et al). 2007;46: rosiglitazone on the liver histology
adiponectin. 2007;46:130-139 991-998
and mitochondrial function in ob/ob
Firlinger F (see Lenz K et al). 2007;46:604 Fried MW (see Feld JJ et al). 2007;46: mice. 2007;46:414-423
(Correspondence) 1548-1563
— (see Solis-Herruzo JA and Garcia-Ruiz
Fischer U (see Volkmann X et al). 2007;46: Friedman S (see Huang H et al). 2007;46: 1). 2007;46:2045-2046 (Reply)
1498-1508 297-306 Garcia-Samaniego ] and Forns X. Hepatitis
Fischer W (see Timm J et al). 2007;46:339- Friedman SL (see Tugues S et al). 2007;46:
C virus and human
349 Fuchsb1i9c1h9l-er1 92A6 (see Stumptner C et al). immunodeficiency virus: The un-won
Fisher RA (see Trotter JF et al). 2007;46:
1476-1484 Fujisa2w0a0 7J; 4(6se:e8 5M at1s-u8z6a0k i K et al). 2007;46: Garciaba-tTtslea.o 2G0,0 7;Sa4n6y:a6l1 A1J-,6 1G4r ac(eE diNtoDr,i al)
Fladeby C (see Mousavi SA et al). 2007;46: 48-57 Carey W, Practice Guidelines
871-884
FungJ (see Yuen MF et al). 2007;46:1695- Committee of the American
Flamm S (see Jacobson IM et al). 2007;46:
Association for the Study of Liver
1703
971-981
Funk A (see Mhamdi M et al). 2007;46:95- Diseases, the Practice Parameters
Flavell RA (see Watanabe A et al). 2007;46:
106 Committee of the American College
1509-1518 Fusco MJ (see Lewis JH et al). 2007;46: of Gastroenterology. Prevention and
Fleischer R (see Sherman KE et al). 2007;
1453-1463 management of gastroesophageal
46:2014-2020 (Special Article)
varices and variceal hemorrhage in
Flisiak R (see Buster EHC] et al). 2007;46:
cirrhosis. 2007;46:922-938 (AASLD
388-394
Practice Guidelines), 2052
Flye NL (see Peters MG et al). 2007;46:
(Correction)
769-775 Gabbi C (see Bertolotti M et al). 2007;46: — (see Peters MG et al). 2007;46:769-775
Fong DYT (see Yuen MF et al). 2007;46: 1664 (Correspondence)
Gary-Bobo M, Elachouri G, Gallas JF,
1695-1703 Gaeta GB, Stroffolini T, Smedile A, Niro
Janiak P, Marini P, Ravinet-Trillou
Fontaine H (see Vallet-Pichard A et al). G, Mele A. Hepatitis delta in Europe:
C, Chabbert M, Cruccioli N,
2007 ;46:32-36 Vanishing or refreshing? 2007;46:
Fontana RJ (see Yee LJ et al). 2007;46:74- 1312-1313 (Correspondence) PfersdorffC ,R oque C, Arnone M,
Croci T, Soubrié P, Oury-Donat F,
83 Gaeta GB (see Stroftolini T et al). 2007;46:
Forbes SJ (see Russo FP et al). 2007;46: 608-609 (Correspondence) Maffrand JP, Scatton B, Lacheretz F,
604-605 (Correspondence) Gaitantzi H (see Weng HL et al). 2007;46: Le Fur G, Herbert JM, Bensaid M.
Rimonabant reduces obesity-
Forestier N, Reesink HW, Weegink CJ, 1257-1270
associated hepatic steatosis and
McNair L, Kieffer TL, Chu HM, Gallas JF (see Gary-Bobo M et al). 2007;
features of metabolic syndrome in
Purdy S, Jansen PLM, Zeuzem S. 46:122-129
Antiviral activity of telaprevir (VX- Galler GW (see Jacobson IM et al). 2007; obese Zucker fa/fa rats. 2007;46:122-
950) and peginterferon alfa-2a in 46:982-990 129
patients with hepatitis C. 2007;46: Gallus S (see Bravi F et al). 2007;46:430- Gatopoulouu A (see Koulaouzidis A et al).
640-648 435 2007;46: 1666-1667
Forestier N (see Kieffer TL et al). 2007;46: Galmozzi A (see Mitro N et al). 2007;46: (Correspondence)
631-639 885-897 Gatti D, Maki A, Chesler EJ, Kirova R,
Forns X (see Garcia-Samaniego J and Forns Ganey PE, Luyendyk JP, Newport SW, Kosyk O, Lu L, Manly KF, Williams
X). 2007;46:61 1-614 (Edixorial) Eagle TM, Maddox JF, Mackman N, RW, Perkins A, Langston MA,
Frahm N (see Timm J et al). 2007;46:339- Roth RA. Role of the coagulation Threadgill DW, Rusyn I. Genome-
349 system in acetaminophen-induced level analysis of genetic regulation of
Franceschi S (see Bravi F et al). 2007;46: hepatotoxicity in mice. 2007;46: liver gene expression networks. 2007;
430-435 1177-1186 46:548-557
Francoz C (see Thabut D et al). 2007;46: Gangloff A (see Thabut D et al). 2007;46: Gauler G (see Stojakovic T et al). 2007;46:
1872-1882 1872-1882 776-784
Vill AUTHOR INDEX HEPATOLOGY, December 2007
Gavrilova O (see Cui Y et al). 2007;46:504- Godofsky E (see Jacobson IM et al). 2007; gallstone risk in humans conferred by
513 46:97 1-981 common variant of hepatic ATP-
Ge L (see Wang Z ct al). 2007;46:2003- Godoy P (see Weng HL et al). 2007;46: binding cassette transporter for
2013 1257-1270 cholesterol. 2007;46:793-801
Gebhardt R (see Weng HL et al). 2007;46: Goeser T (see Nierhoff D et al). 2007;46: — (see Nattermann J et al). 2007;46:1016-
1257-1270 535-547 1025
Geerts A. The simple truth is seldom true Goetz M (see Kariwal F et al). 2007;46: GuéchotJ (see Lewin M et al). 2007;46:
and never simple: Dual role for 1741-1749 658-665
p75*'® in transdifferentiation and cell Gold EB (see Selmi C et al). 2007;46:1836- Guerra B (see Lanford RE et al). 2007;46:
death of hepatic stellate cells. 2007; 1843 999-1008
46:600-601 (Hepatology Elsewhere) Gollan J (see Harrison-Findik DD et al). Guevara M (see Ginés P and Guevara M).
Gefen-Halevi S (see Meivar-Levy I et al). 2007 ;46:1979-1985 2007 ;46: 1685-1687 (Editorial)
Gomes DA (see Watanabe A et al). 2007; Guichard C (see Thabut D et al). 2007;46:
2007;46:898-905
Geller DA (see Stolz DB et al). 2007;46: 46:1509-1518 1893-1906
Gémez-Mateos JM (see Pineda JA et al). Guichelaar MMJ, Schmoll J, Malinchoc
1464-1475
Gentilin B (see Miozzo M et al). 2007;46: 2007;46:622-630 M, Hay JE. Fractures and avascular
Gonde C (see Narayanaswamy B et al). necrosis before and after orthotopic
456-462
GeorgeJ (see Cua IHY and George J). 2007;46:180-187 liver transplantation: Long-term
2007;46:2051 (Reply) Gonzalez-Gomez I (see Wong LJC et al). follow-up and predictive factors.
— (see Cua IHY et al). 2007;46:66-73 2007;46:1218-1227 2007;46:1 198-1207
Gonzalez-Serrano M (see Pineda JA et al). Guimont MC (see Thabut D et al). 2007;
— (see Van der Poorten D et al). 2007;46:
2007;46:622-630 46:1893-1906
1750-1758 Goodman Z (see Calvert VS et al). 2007; Giilberg V, Gerbes AL, Sauerbruch T,
Geppert CMA and Arora S$. Widening the Appenrodt B. Insufficient sensitivity
door: The evolution of hepatitis C 46:166-172, 1315-1316 (Correction) of reagent strips for spontaneous
Gordon FD (see Shah NL and Gordon
treatment in patients with psychiatric FD). 2007;46:939-941 (Hepatology bacterial peritonitis. 2007;46:1669
disorders. 2007;46:957-959 Elsewhere) (Correspondence)
(Editorial) Gordon SC (see McHutchison JG et al). Gumpricht E (see Soden JS et al). 2007;46:
Gerbes AL (see Giilberg V et al). 2007;46: 2007 ;46:1341-1349 485-495
1669 (Correspondence) Guo D (see Yood MU et al). 2007;46:107-
Gores GJ (see Mott JL and Gores G)).
Gerken G (see Wu J et al). 2007;46:1769- 2007;46:906-911 (Review) 112
1778 Guo G (see Maher JM et al). 2007;46:
Gorman N, Zaharia A, Trask HS, Szakacs
Gershwin ME (see Leung PSC). 2007;46: JG, Jacobs NJ, Jacobs JM, Balestra D, 1597-1610
1436-1442 Gurakuqi G (see Stojakovic T et al). 2007;
Sinclair JF, Sinclair PR. Effect of an
— (see Miozzo M et al). 2007;46:456-462 oral iron chelator or iron-deficient 46:776-784
— (see Selmi C et al). 2007;46:1836-1843 diets on uroporphyria in a murine Gutsche J (see Schaefer M et al). 2007;46:
Gerstner J (see Fernandes F et al). 2007;46: model of porphyria cutanea tarda. 991-998
1026-1033
2007 :46:1927-1934
Getachew Y (see Stout-Delgado HW et al).
Gornbein J (see Hassanein TI et al). 2007;
2007;46:1530-1540
46:1853-1862
Ghany M (see Lutchman G et al). 2007;46:
Gorrell MD. Liver fibrosis: The hepatocyt Haas JE (see Soden JS et al). 2007;46:485-
Ghany4 24M-G4 29( see Lok AS et al). 2007;46: (reHveipsiatteod.l og2y0 07E;ls4e6w:h1e6re5)9 -1661 495
Haber BA (see DeRusso PA et al). 2007;46:
254-265 (Review) Govindarajan S (see Yuan JM et al). 2007; 1632-1638 (Special Article)
— (see Yee LJ et al). 2007;46:74-83
46:749-758 Haber PS and McCaughan GW. “I'll never
Ghosh K (see Lazaridis KN et al). 2007;46: Grace ND (see Garcia-Tsao G et al). 2007; touch it again, doctor!” —- Harmful
785-792 46:922-938 (AASLD Practice drinking after liver transplantation.
Giannelli G (see Bergamini C et al). 2007; Guidelines), 2052 (Correction) 2007;46: 1302-1304 (Hepatology
46:1801-1809 GrallaJ (see Soden JS et al). 2007;46:485- Elkewhere)
Gifford A (see Kanwal F et al). 2007;46: 495 Haberstroh A (see Zeisel MB et al). 2007;
1741-1749 Grati FR (see Miozzo M et al). 2007;46: 46:1722-1731
Gilardi F (see Mitro N et al). 2007;46:885- 456-462 Hadzic N (see Davenport M et al). 2007;
897 Greene CM (see Miller SDW et al). 2007; 46:1821-1827
Giltiay N (see Rutkute K et al). 2007;46:
46:496-503 Haerter G (see Nattermann J et al). 2007;
1166-1176 Griffel LH (see Jacobson IM et al). 2007; 46:1016-1025
Ginés P and Guevara M. Therapy with
46:97 1-981, 982-990 Hakem SA (see Kamal SM et al). 2007;46:
vasoconstrictor drugs in cirrhosis: The Grilo I (see Pineda JA et al). 2007;46:622- 1732-1740
time has arrived. 2007;46:1685-1687 630 HalangkJ (see Schaefer M et al). 2007;46:
(Editorial) Gripon P (see Schulze A et al). 2607;46: 991-998
Gish RG (see Pockros PJ et al). 2007;46: 1759-1768 Halfon P, Penaranda G, Renou C,
324-329 Gritsenko MA (see Diamond DL et al). Bourliere M. External validation of
Gnerre C (see Peyer AK et al). 2007;46: 2007 ;46:649-657 Fibrolndex. 2007;46:280-28 1
1960-1970 Grundy SM (see Vega GL et al). 2007;46: (Correspondence)
Gobejishvili L (see Joshi-Barve S et al). 716-722 Hall C (see Bernal W et al). 2007;46:1844-
2007;46:823-830 Griinhage F, Acalovschi M, Tirziu S$, Walier 1852
Godio C (see Mitro N et al). 2007;46:885- M, Wienker TF, Ciocan A, Mosteanu Hamad ARA (see Ma X et al). 2007;46:
897 O, Sauerbruch T, Lammert F. Increased 1519-1530
HEPATOLOGY, Vol. 46, No. 6, 2007 AUTHOR INDEX IX
Hamano H (see Umemura T et al). 2097; signaling in the liver. 2007;46:1791- Hoang T (see Kanwal F et al). 2007;46:
46:463-471 1800 1741-1749
Hamdi H, Bigorgne A, Naveau S, Balian He M (see Chen Y et al). 2007;46:200-208, Hodges SJ (see Mookerjee RP et al). 2007;
A, Bouchete-Delbos L, Cassard- 1314 (Correction) 46:83 1-840, 2052 (Correction)
Doulcier AM, Maillot MC, Durand- Heathcote EJ (see Feld JJ et al). 2007;46: — (see Wright G et al). 2007;46:610
Gasselin I, Prévot S$, Delaveaucoupet 1057-1070 (Correction)
J, Emilie D, Perlemuter G. — (see Nelson JE et al). 2007;46:723-729 Hoeffel C (see Lewin M et al). 2007;46:
Glucocorticoid-induced leucine Hecht D (see Pockros PJ et al). 2007;46: 658-665
zipper: A key protein in the 324-329 Hoefs JC and Morgan TR. Seventy-two
sensitization of monocytes to Heim MH (see Christen V et al). 2007;46: weeks of peginterferon and ribavirin
lipopolysaccharide in alcoholic 558-565 for patients with partial early virologic
hepatitis. 2007;46: 1986-1992 Heinz A (see Schaefer M et al). 2007;46: response? 2007;46:1671-1674
Hammersen F] (see Brulport M et al). 991-998 (Editorial)
2007;46:861-870 Heller J (see TrebickaJ et al). 2007;46:242- Hohenberg H (see Mhamdi M et al). 2007;
Hamzavi J (see Weng HL et al). 2007;46: 253, 1310 (Reply) 46:95-106
1257-1270 Heller T (see Lutchman G et al). 2007;46: Hollingshead BD (see Patel RD et al).
Han BH (see Yoo BC et al). 2007;46:1041- 424-429 2007;46:209-218
1048 Hellerbrand C and Wasmuth HE. Holstein-Rathlou NH (see Krag A et al).
Han JY (see Yoo BC et al). 2007;46:1041- Genomewide genetic association 2007;46: 1863-1871
studies in hepatology: The end of Homburger HA (see Lazaridis KN et al).
1048
Han S (see Spiegel BMR et al). 2007;46: searching for the needle in the 2007;46:785-792
113-121 haystack? 2007;46:1661-1663 Honda M (see Matsuzawa N et al). 2007;
Han SHB. 2007;46:953-956 (Editorial) (Hepatology Elewhere) 46:1392-1403
Hengstler JG (see Brulport M et al). 2007; Hong EK (see Kong SY et al). 2007;46:
Handa T (see Morita S et al). 2007;46:188-
46:86 1-870 446-455
199
Hennenberg M (see TrebickaJ et al). 2007; Hong Kong Liver Fibrosis Study Group
Hansen BE (see Buster EHC] et al). 2007;
46:242-253 (see Hui CK et al). 2007;46:395-401
46:388-394
Hennighausen L (see Cui Y et al). 2007;46: — (see Hui CK et al). 2007;46:690-698
Harada K, Sato Y, Itatsu K, Isse K, Ikeda
504-513 Hoofnagle JH (see Lutchman G et al).
H, Yasoshima M, Zen Y, Matsui A,
Henriksen JH. New cholestatic mouse 2007 ;46:424-429
Nakanuma Y. Innate immune
model provides insights into renal — (see Modi AA and Hoofnagle JH).
response to double-stranded RNA in
reabsorption of sodium. 2007;46:9-11 2007;46:615-617 (Editorial)
biliary epithelial cells is associated
(Editorial) — (see Sokol RJ et al). 2007;46:566-581
with the pathogenesis ofb iliary
— (see Krag A et al). 2007;46:1863-1871 (Review)
atresia. 2007;46:1146-1154
Hepatitis B Virus Drug Resistance Hoover S (see Fernandes F et al). 2007;46:
Hargrave T (see Jacobson IM et al). 2007;
Working Group (see Lok AS et al). 1026-1033
46:982-990
2007;46:254-265 (Review) Hoppel CL (see Wong LJC et al). 2007;46:
Harrison-Findik DD, Klein E, Crist C, Herbert JM (see Gary-Bobo M et al). 2007; 1218-1227
Evans J, Timchenko N, Gollan J. Iron- 46:122-129 Horn LC (see Brulport M et al). 2007;46:
mediated regulation of liver hepcidin
Herkel J, Manns MP, Lohse AW. 861-870
expression in rats and mice is abolished
Selenocysteine, soluble liver antigen/ Hosaka T (see Akuta N et al). 2007;46:
by alcohol. 2007;46:1979-1985
liver-pancreas, and autoimmune 1357-1364
Harry D (see Wright G et al). 2007;46:610
hepatitis. 2007;46:275-277 Hosui A (see Cui Y et al). 2007;46:504-513
(Correction) (Hepatology Elsewhere) Hote P (see Joshi-Barve S et al). 2007;46:
Hartig W (see Brulport M et al). 2007;46:
Hermes M (see Brulport M et al). 2007;46: 823-830
861-876 861-870 Hraber P, Kuiken C, Yusim K. Evidence
HarveyJ (see Jacobson IM et al). 2007;46: Herr I, Schemmer P, Biichler MW. On the for human leukocyte antigen
982-990 TRAIL to therapeutic intervention in heterozygote advantage against
Hashem M (see Kamal SM et al). 2007;46: liver disease. 2007;46:266-274 hepatitis C virus infection. 2007;46:
1732-1740
(Review) 1713-1721
Hashmi A (see Watanabe A et al). 2007;46: Heuchel R (see Weng HL et al). 2007;46: Hsiao M (see Liu SP et al). 2007;46:1413-
1509-1518 1257-1270 1425
Hassanein TI, Tofteng F, Brown RS Jr, Hickman I and Macdonald G. Is vitamin E Hu CP (see Chou YC et al). 2007;46:672-
McGuire B, Lynch P, Mehta R, beneficial in chronic liver disease? 681
Larsen FS, Gornbein J, Stange J, Blei 2007;46:288-290 (Editorial) HuaJ (see Ma X et al). 2007;46:1519-1530
AT. Randomized controlled stufy of Higashiyama R (see Inagaki Y et al). 2007; Huang H, Shiffman ML, Friedman S,
extracorporeal albumin dialysis for 46:605-606 (Reply) Venkatesh R, Bzowej N, Abar OT,
hepatic encephalopathy in advanced Hill D (see Joshi-Barve S et al). 2007;46: Rowland CM, Catanese JJ, Leong
cirrhosis. 2007;46:1853-1862 823-830 DU, Sninsky JJ, Layden TJ, Wright
Haurie V (see Rousseau B et al). 2007;46: Hines IN, Kremer M, Isayama F, Perry TL, White T, Cheung RC. A 7 gene
1108-1118 AW, Milton RJ, Black AL, Byrd CL, signature identifies the risk of
Hay JE (see Guichelaar MMJ et al). 2007; Wheeler MD. Impaired liver developing cirrhosis in patients with
46:1198-1207 regeneration and increased oval cell chronic hepatitis C. 2007;46:297-306
Hayashi N (see Sakamori R et al). 2007;46: numbers following T cell-mediated HuangJ , Iqbal J, Saha PK, Liu J, Chan L,
1564-1573 hepatitis. 2007;46:229-241 Hussain MM, Moore DD, Wang L.
He J, de la Monte S, Wands JR. Acute Hinzpeter A (see Schaefer M et al). 2007; Molecular characterization of the role
ethanol exposure inhibits insulin 46:99 1-998 of orphan receptor small heterodimer
X AUTHOR INDEX HEPATOLOGY, December 2007
partner in development of fatty liver. lloeje U (see Yood MU et al). 2007;46:107- L, Galler GW, Araya V, Freilich B,
2007 ;46:147-157 112 Harvey J, Griffel LH, Brass CA.
Huang Y (see Feld JJ et al). 2007;46:1548- Im KA (see Rosen HR et al). 2007;46:350- Impact of weight-based ribavirin with
1563 358 peginterferon alfa-2b in African
Hubbard S (see Shiffman ML et al). 2007; — (see Yee LJ et al). 2007;46:74-83 Americans with hepatitis C virus
46:37 1-379 Imbeaud S (see Bioulac-Sage P et al). 2007; genotype 1. 2007;46:982-990
Huerga E (see Rovira A et al). 2007;46: 46:740-748 — (see McHutchison JG et al). 2007;46:
1485-1490 Imbert-Teboul M (see Ackermann D et al). 1341-1349
Hughes RD (see Mitry RR et al). 2007;46: 2007;46:173-179 Jaeck D (see Zeisel MB et al). 2007;46:
2047-2048 (Correspondence) Imeryuz N (see Tahan V et al). 2007;46: 1722-1731
Hugues M (see Rousseau B et al). 2007;46: 2045 (Correspondence)
Jalan R (see Mookerjee RP et al). 2007;46:
1108-1118 Inagaki Y, Higashiyama R, Watanabe T, 831-840, 943-946 (Hepatology
Hui C (see Chen Y et al). 2007;46:200- Okazaki I. Bone marrow cells in the Elsewhere), 2052 (Correction)
208, 1314 (Correction) liver: Diverse cells, diverse effects. — (see Rose C et al). 2007;46:1883-1892
Hui CK, Leung N, Shek TWH, Yao H, 2007;46:605-606 (Reply) — (see Wright G and Jalan R). 2007;46:
Lee WK, Lai JY, Lai ST, Wong WM, Inoue K, Watanabe T, Yoshiba M, Kohara
291-294 (Editorial)
Lai LSW, Poon RTP, Lo CM, Fan M. Hepatitis C virus RNA kinetics in
— (see Wright G et al). 2007;46:610
ST, Lau GKK, Hong Kong Liver chimeric mice with human
(Correction)
Fibrosis Study Group. Sustained hepatocytes during antiviral therapy.
Janiak P (see Gary-Bobo M et al). 2007;46:
disease remission after spontaneous 2007;46:2049-2050
122-129
HBeAg seroconversion is associated (Correspondence)
Jansen PLM (see Forestier N et al). 2007;
with reduction in fibrosis progression Invernizzi P (see Miozzo M et al). 2007;46:
in chronic hepatitis B Chinese 456-462 46:640-648
Janssen G (see Schaefer M et al). 2007;46:
patients. 2007;46:690-698 — (see Selmi C et al). 2007;46:1836-1843
—, Leung N, Yuen ST, Zhang HY, Leung lolascon A (see Persico M et al). 2007;46: 991-998
Janssen HLA (see Buster EHC] et al).
KW, Lu L, Cheung SKF, Wong WM, 1009-1015
Lau GK, Hong Kong Liver Fibrosis Iqbal J (see HuangJ et al). 2007;46:147- 2007;46:388-394
— (see Stoop JN et al). 2007;46:699-705
Study Group. Natural history and 157
disease progression in Chinese chronic Isayama F (see Hines IN et al). 2007;46: Jeng KS (see Chou YC et al). 2007;46:672-
hepatitis B patients in immune- 229-241 681
tolerant phase. 2007;46:395-401 Isse K (see Harada K et al). 2007;46:1146- Jeong SH (see Yoo BC et al). 2007;46:
Hui JM (see Cua IHY et al). 2007;46:66-73 1154 1041-1048
HungJH (see Lu YS et al). 2007;46:1119- — (see Lunz JG III et al). 2007;46:1946- Jhaveri R and Murray N. AASLD Practice
1130 1959 Guidelines on Chronic Hepatitis B.
Huo TI, Wu JC, Lee SD. Does hepatitis B Itatsu K (see Harada K et al). 2007;46: 2007;46:280 (Correspondence)
viral load determine the outcome of 1146-1154 Ji C, Shinohara M, Kuhlenkamp J, Chan
patients with hepatocellular C, Kaplowitz N. Mechanisms of
carcinoma undergoing chemotherapy? protection by the betaine-
2007;46: 1665-1666 J homocysteine
(Correspondence) methyltransferase/betaine system in
Hussain M (see Narayanaswamy B et al). Jacas C (see Rovira A et al). 2007;46:1485- HepG2 cells and primary mouse
2007;46: 180-187 1490 hepatocytes. 2007;46: 1586-1596
Hussain MJ (see Longhi MS et al). 2007; Jackson H, Solaymani-Dodaran M, Card Jia LT (see Wen WH et al). 2007;46:84-94
46:472-484 TR, Aithal GP, Logan R, West Jiménez W (see Tugues S et al). 2007;46:
Hussain MM (see HuangJ et al). 2007;46: J. Influence of ursodeoxycholic acid 1919-1926
on the mortality and malignancy
147-157 Jin BQ (see Wen WH et al). 2007;46:84-94
Huyghe M (see Pockros PJ et al). 2007;46: associated with primary biliary Jin L (see Morford LA). 2007;46:1541-
324-329 cirrhosis: A population-based cohort 1547
study. 2007;46:1131-1137
HwangJS (see Yoo BC et al). 2007;46: Jin X, Zhang Z, Beer-Stolz D, Zimmers
1041-1048 Jacobs JM (see Diamond DL et al). 2007; TA, Koniaris LG. Interleukin-6
Hwang SF (see Liu SP et al). 2007;46: 46:649-657 inhibits oxidative injury and necrosis
1413-1425 — (see Gorman N et al). 2007;46:1927-
1934 after extreme liver resection. 2007;46:
Hwang SG (see Yoo BC et al). 2007;46:
802-812
1041-1048 Jacobs NJ (see Gorman N et al). 2007;46: Joseph TA (see Saab S et al). 2007;46:
Hwa-Ong S (see Spiegel BMR et al). 2007; 1927-1934
46:113-121 Jacobson IM, Brown RS Jr, Freilich B, 1049-1056
Afdhal N, Kwo PY, Santoro J, Becker Joshi-Barve S, Barve SS, Amancherla K,
S, Wakil AE, Pound D, Godofsky E, Gobejishvili L, Hill D, Cave M, Hote
Strauss R, Bernstein D, Flamm S, P, McClain CJ. Palmitic acid induces
Pauly MP, Mukhopadhyay P, Griffel production of proinflammatory
Ibrahiem A (see Kamal SM et al). 2007;46: LH, Brass CA, WIN-R Study Group. cytokine interleukin-8 from
1732-1740 Peginterferon alfa-2b and weight- hepatocytes. 2007;46:823-830
Ikeda A (see Stolz DB et al). 2007;46:1464- based or flat-dose ribavirin in chronic Jouvin-Marche E (see Bonorino P et al).
1475 hepatitis C patients: A randomized 2007;46:1375-1386
Ikeda H (see Harada K et al). 2007;46: trial. 2007;46:97 1-981 Jung D (see Peyer AK et al). 2007;46:1960-
1146-1154 —., Brown RS Jr, McCone J, Black M, 1970
Ikeda K (see Akuta N et al). 2007;46:1357- Albert C, Dragutsky MS, Siddiqui Juran BD (see Lazaridis KN et al). 2007;46:
1364 FA, Hargrave T, Kwo PY, Lambiase 785-792